The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study.
about
Antimicrobial Peptides in Human SepsisThe Endothelial Glycocalyx: New Diagnostic and Therapeutic Approaches in SepsisTherapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal SepsisThe β-d-Endoglucuronidase Heparanase Is a Danger Molecule That Drives Systemic Inflammation and Correlates with Clinical Course after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair: Lessons Learnt from Mice and MenYear in review 2013: Critical Care--sepsis.Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serumThe Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human SepsisUse of Biotelemetry to Define Physiology-Based Deterioration Thresholds in a Murine Cecal Ligation and Puncture Model of Sepsis.The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsisTherapeutic utility of antibacterial peptides in wound healing.A review on comparative mechanistic studies of antimicrobial peptides against archaea.The synthetic antimicrobial peptide 19-2.5 attenuates mitochondrial dysfunction in cardiomyocytes stimulated with human sepsis serum.The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways.Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbits.Low-dose polymyxin: an option for therapy of Gram-negative sepsis.Mechanism of Hbγ-35-induced an increase in the activation of the human immune system by endotoxins.
P2860
Q26782811-C4F2E82E-1502-49A5-9679-2473016DB906Q28072373-EC43FE70-6EA7-423F-AF21-7909D5704A5DQ28546690-7D46BBBC-FEDB-463B-BD01-BD5717CF4308Q33785612-FE39A7B6-5419-438B-A1A1-4AC3D66FA8CFQ35091080-02B9DD35-3397-4355-9F7A-B03816D52F5CQ35646306-EA568944-2A61-4183-84DC-07396133439CQ35850606-F418EBAA-FAD2-4D44-935D-C71F3E28D57DQ36905589-D7E546D0-33CC-490E-901D-102D6BF6F267Q37419083-00EEEC71-E99D-42FC-AFA3-6D41A682533BQ38401924-6B28006D-1276-4EE1-BF17-F3FF356991B7Q38653377-8CA72BF4-0BE5-4200-8F9F-12914F611812Q38746473-066F2D78-ADDF-408B-B343-8BFC3B7F5BF0Q38807115-60701576-6179-4ED0-9557-F4DBDB48F7BEQ40170272-BB292915-07BD-41CD-B25B-1752B3103558Q40272427-13659BA3-80A6-46C1-AE64-F6AF61418E95Q49996616-3EE7C509-939B-485E-AF09-6A7987F084DA
P2860
The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The anti-inflammatory effect o ...... prospective randomized study.
@en
type
label
The anti-inflammatory effect o ...... prospective randomized study.
@en
prefLabel
The anti-inflammatory effect o ...... prospective randomized study.
@en
P2093
P2860
P356
P1433
P1476
The anti-inflammatory effect o ...... prospective randomized study.
@en
P2093
Gernot Marx
Lena Heinbockel
Lukas Martin
Mathias Hornef
Sabine Doemming
Tim-Philipp Simon
Tobias Schuerholz
P2860
P2888
P356
10.1186/CC11920
P577
2013-01-09T00:00:00Z
P5875
P6179
1047118105